These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37490668)

  • 1. [Efficacy and safety of non-immunogenic staphylokinase in the ischemic stroke in real-world clinical practice in the Sverdlovsk region].
    Alasheev AM; Lantsova EV; Tretyakov DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7):74-79. PubMed ID: 37490668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
    Gusev EI; Martynov MY; Nikonov AA; Shamalov NA; Semenov MP; Gerasimets EA; Yarovaya EB; Semenov AM; Archakov AI; Markin SS;
    Lancet Neurol; 2021 Sep; 20(9):721-728. PubMed ID: 34418399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravenous thrombolytic therapy of ischemic stroke with the drug Revelisa in real clinical practice: results of the IVT-AIS-R study].
    Soldatov MA; Klimov LV; Tolmachev AP; Kiseleva TV; Androfagina OV; Beketova EM; Belkina SN; Borisov DN; Karpov DY; Krasyuk MS; Kucheryavaya MV; Minina YD; Novikov DG; Rogozhnikova NV; Tabakman SV; Teliatnik YA; Tretyakov KV; Fadeeva AS; Khan DS; Chirkov AN; Marskaya NA; Shamalov NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(12. Vyp. 2):42-49. PubMed ID: 36582160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of alteplase treatment in patients with acute ischemic stroke with unknown time of onset: -Real world data.
    Terasawa Y; Shimomura R; Sato K; Himeno T; Inoue T; Kohriyama T
    J Clin Neurosci; 2023 Jan; 107():124-128. PubMed ID: 36535219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [First case of thrombolysis with non-immunogenic staphylokinase in a patient with ischemic stroke receiving dabigatran etexilate followed by thrombectomy].
    Ramazanov GR; Kokov LS; Shamalov NA; Kovaleva EA; Klychnikova EV; Akhmatkhanova LK; Cheboksarov DV; Khamidova LT; Muslimov RS; Rybalko NV; Petrikov SS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(6):145-151. PubMed ID: 35758961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nonimmunogenic staphylokinase in the treatment of acute ischemic stroke (FRIDA trial results)].
    Gusev EI; Martynov MY; Shamalov NA; Yarovaya EB; Semenov MP; Semenov AM; Orlovsky AA; Kutsenko VA; Nikonov AA; Aksentiev SB; Yunevich DS; Alasheev AM; Androfagina OV; Bobkov VV; Choroshavina KV; Gorbachev VI; Korobeynikov IV; Greshnova IV; Dobrovolskiy AV; Elemanov UA; Zhukovskaya NV; Zakharov SA; Chirkov AN; Korsunskaya LL; Nesterova VN; Nikonova AA; Nizov AA; Girivenko AI; Ponomarev EA; Popov DV; Pribylov SA; Semikhin AS; Timchenko LV; Jadan ON; Fedyanin SA; Chefranova ZY; Lykov YA; Chuprina SE; Vorobev AA; Archakov AI; Markin SS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7):56-65. PubMed ID: 35904293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Independence of ischemic stroke patients after alteplase systemic thrombolytic therapy].
    Belkina SN; Kotov SV; Isakova EV; Kotov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12. Vyp. 2):56-61. PubMed ID: 35044127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis for acute ischaemic stroke with alteplase in an Asian population: results of the multicenter, multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World (SITS-NEW).
    Rha JH; Shrivastava VP; Wang Y; Lee KE; Ahmed N; Bluhmki E; Hermansson K; Wahlgren N;
    Int J Stroke; 2014 Oct; 9 Suppl A100():93-101. PubMed ID: 22988894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of intravenous thrombolytic treatment in wake-up stroke: Experiences from a single center.
    Wiśniewski A
    Brain Behav; 2021 Jun; 11(6):e02152. PubMed ID: 33939326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Different Dosages of Alteplase in Atrial Fibrillation-Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan.
    Lin SF; Chen CF; Hu HH; Ho BL; Chen CH; Chan L; Lin HJ; Sun Y; Lin YY; Chen PL; Lin SK; Wei CY; Lin YT; Lee JT; Chao AC;
    J Am Heart Assoc; 2022 Feb; 11(3):e023032. PubMed ID: 35048714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of thrombolytic agents in treatment of patients with acute ischemic stroke; findings from a single centre follow up study in real-life settings.
    George M; Baby N; Paul R; Zabeer M; Thomas C
    J Clin Neurosci; 2021 Sep; 91():299-305. PubMed ID: 34373043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcranial Pulsed Ultrasound with Alteplase Intravenous Thrombolysis for Vascular Recanalisation in Acute Ischemic Stroke.
    Chen Z; Zhang J
    J Coll Physicians Surg Pak; 2020 Jul; 30(7):765-767. PubMed ID: 32811613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS).
    Nakagawara J; Minematsu K; Okada Y; Tanahashi N; Nagahiro S; Mori E; Shinohara Y; Yamaguchi T;
    Stroke; 2010 Sep; 41(9):1984-9. PubMed ID: 20651262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
    Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous thrombolytic therapy with Revelisa of ischemic stroke in real-world clinical practice: interim results of an open-label, prospective, multicenter, non-interventional study IVT-AIS-R].
    Soldatov MA; Marskaya NA; Barsegova KA; Androfagina OV; Borisov DN; Karpov DY; Kishinevsky MV; Kucheryavaya MV; Tabakman SV; Telyatnik YA; Fadeeva AS; Khan DS; Chirkov AN; Shamalov NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):33-37. PubMed ID: 33908230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteplase for Stroke With Unknown Onset Time in Chronic Kidney Disease: A Pooled Analysis of Individual Participant Data.
    Miwa K; Koga M; Jensen M; Inoue M; Yoshimura S; Fukuda-Doi M; Boutitie F; Ma H; Ringleb PA; Wu O; Schwamm LH; Warach S; Hacke W; Davis SM; Donnan GA; Gerloff C; Thomalla G; Toyoda K;
    Stroke; 2022 Nov; 53(11):3295-3303. PubMed ID: 35997023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocol.
    Bivard A; Garcia-Esperon C; Churilov L; Spratt N; Russell M; Campbell BC; Choi P; Kleinig T; Ma H; Markus H; Molina C; Hsu C; Tsai CH; Meretoja A; Strbian D; Butcher K; Wu T; Davis S; Donnan G; Levi C; Parsons M
    Int J Stroke; 2023 Jul; 18(6):751-756. PubMed ID: 36655938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis in young adults with ischemic stroke.
    Putaala J; Metso TM; Metso AJ; Mäkelä E; Haapaniemi E; Salonen O; Kaste M; Tatlisumak T
    Stroke; 2009 Jun; 40(6):2085-91. PubMed ID: 19372446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.